Skip to main content

Life Sciences is now live. See how →

Patent Examiner Jeffrey Gerben Hoekstra

Art Unit 3791 · Physiological Measurement, Analyte Sensors & Sample Collection · Tech Center 3700 · 206 applications filed 2021–2026

⚑ Very Hard · harder than 81% of examiners● Free examiner data

Jeffrey Gerben Hoekstra is a USPTO patent examiner in Art Unit 3791 (Physiological Measurement, Analyte Sensors & Sample Collection) with 206 applications from filing years 2021–2026. Examiner Hoekstra's allowance rate is 62.0%, below the 84.3% USPTO average for applications filed in the same years. The examiner ranks harder than 81% of examiners. In 2023, decided applications with an examiner interview were allowed 35.7 percentage points more often than those without.

Data through November 2026 from USPTO Patent Center (formerly PAIR) · Methodology

Overview

Free
Difficulty · Very Hard
harder than 81% of examiners
Easier81st percentileHarder
Allowance rate vs peers
Examiner Hoekstra62.0%
Art Unit 379168.1%
USPTO average84.3%
Allowance rate
62.0%
▼ USPTO avg 84.3%
Applications
206
filing years 2021–2026
First-action allowance
2.8%
patented with no rejection
Abandoned
13.1%
share of applications
Avg office actions
1.3
USPTO avg 1.1
Days to first OA
846
▲ USPTO 600
RCE rate
18.9%
USPTO 16.1%
Interview rate
17.5%
USPTO 23.7%

Examiner details

  • Art unit3791 · Physiological Measurement, Analyte Sensors & Sample Collection
  • Title / gradeSupervisory Patent Examiner · GS-15
  • Service21 years
  • PhoneOn each office action
  • In USPTO recordsHOEKSTRA, JEFFREY GERBEN
Full signatory authority

Examiner Hoekstra can allow an application without a supervisory sign-off.

Examines (USPC classes)
600 · Surgery

How to improve your odds with Examiner Hoekstra

  • The data favors an interview. Interviewed cases were allowed more often in the one measured year, by 35.7 points.
  • Plan for the timeline. First office action averages 846 days vs the 600-day USPTO norm.
  • Expect a §102. Novelty is the most-issued rejection (116), and applicants overcame it 41.7% of the time.
  • The data favors an RCE here. Cases with an RCE were allowed more often in both measured years, by 34.5 to 61.1 points.

Historical patterns from this examiner's past cases, shown for general information. This is not legal advice and does not predict the outcome of any specific application. Decisions about interviews, RCEs, and claim strategy should be made with a licensed patent attorney or agent.

Rejection patterns & how they get overcome

Free
§101 Eligibility33 issued · 78.6% overcome
§102 Novelty116 issued · 41.7% overcome
§112 Definiteness & disclosure30 issued · 58.3% overcome
How applicants traverse §102 rejections🔒 Members

Applicants overcame 20 of the 48 decided §102 novelty rejections from Examiner Hoekstra in the data. Each winning response, with its arguments and claim amendments, is in the file wrapper.

Read the winning §102 argumentsFull REMARKS, amendments, claim trees & redlines from the file wrappers
Start free

Just got an office action from Examiner Hoekstra?

Draft your response with Examiner Hoekstra's record and Art Unit 3791's history in view, including the rejection patterns, the interview record, and the arguments that have overcome them. See office action responses in AI Studio.

Open AI Studio free →

RCE behavior

Allowance after a Request for Continued Examination versus without one, per year. Use it to judge whether an RCE is worth the cost in front of Examiner Hoekstra.

YearRCE rateAllowance w/ RCEAllowance w/oDelta
202323.3%100.0%65.5%+34.5pp
202231.7%100.0%38.9%+61.1pp

Recent outcomes

Free🔒 Case detail for members
App #TitleOutcomeOAsArguments & redline
18/784804Single-Arm Physiological Signal Measuring SystemPatented1🔒 View
18/023729System and Method for Secondary Brain Insult DetectionPatented2🔒 View
18/125498Methods of Assessing Contact Between an Electrode and Tissue Using Complex Impedance MeasurementsPatented1🔒 View
18/022816Method for Visual Function AssessmentPatented2🔒 View
See all 206 applications with full file-wrapper detailOffice action text, attorney arguments, amendments & claim-by-claim track changes
Start free

Art Unit 3791 technology

Glucose & analyte sensorsBlood pressure & cardiovascular sensingBody movement & force measurementBlood & tissue samplingTop CPC A61B · A61M · G16H
About this examiner. Jeffrey Gerben Hoekstra examines in Art Unit 3791 (Physiological Measurement, Analyte Sensors & Sample Collection, Tech Center 3700).

Frequently asked questions

What is Examiner Jeffrey Gerben Hoekstra's allowance rate?
Examiner Hoekstra's allowance rate is 62.0%, compared with 84.3% across the USPTO and 68.1% in Art Unit 3791 for applications filed in the same years. That rate ranks Examiner Hoekstra harder than 81% of examiners.
Is Examiner Hoekstra a hard examiner?
Yes. Examiner Hoekstra ranks harder than 81% of examiners, in the 81st difficulty percentile (very hard). Examiner Hoekstra has a 62.0% allowance rate versus 84.3% across the USPTO and 68.1% in Art Unit 3791, 1.3 office actions per application versus 1.1, and an RCE rate of 18.9% versus 16.1% across the USPTO, for applications filed in the same years.
Do examiner interviews help with Examiner Hoekstra?
In this examiner's record, yes. Decided applications with an interview were allowed more often in the one measured year, by 35.7 percentage points. In 2023, 100.0% of decided applications with an interview were allowed, versus 64.3% of those without.
What is Examiner Hoekstra's most common rejection?
§102 novelty, issued 116 times in the data. Applicants overcame it 41.7% of the time.
Is an RCE worth filing with Examiner Hoekstra?
In this examiner's record, yes. Decided applications with an RCE were allowed more often in both measured years, by 34.5 to 61.1 percentage points. In 2022, 100.0% of decided applications with an RCE were allowed, versus 38.9% of those without one.
How long until the first office action from Examiner Hoekstra?
About 846 days on average, versus 600 days across the USPTO for applications filed in the same years.

Put Examiner Hoekstra's data to work on your next response.

Full file-wrapper detail, winning arguments, and AI-assisted drafting in one workspace.

Start free
Statistics are computed by Boundly Prosecution Intel from USPTO Patent Center (formerly PAIR) file wrappers for filing years 2021–2026, refreshed regularly. Allowance rate (sometimes called grant rate) is the share of disposed applications that issued as patents. Office actions here are non-final and final rejections, so restriction requirements and allowances are not counted. USPTO benchmarks are weighted to each examiner's mix of filing years, and art-unit benchmarks to the art units and filing years of the examiner's own applications, so they compare like for like. The difficulty percentile ranks examiners, each counted once, so it can point the other way from the USPTO average, which counts applications. See how each number is computed. The year-by-year interview and RCE tables show up to four recent filing years, leaving out the newest one and any year with fewer than ten applications or five decided applications on either side. Historical data is provided for informational purposes only. Past examiner behavior does not guarantee future outcomes, and nothing here is legal advice or a substitute for advice from a licensed patent attorney or agent. Are you Jeffrey Gerben Hoekstra, or see an error? Request a correction.